Invesco Biotechnology & Genome ETF
PBE
PBE
86 hedge funds and large institutions have $121M invested in Invesco Biotechnology & Genome ETF in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 35 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $133M → $121M (-$12M)
46% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 35
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Holders
86
Holding in Top 10
4
Calls
–
Puts
$15K
Top Buyers
| 1 | +$4.3M | |
| 2 | +$606K | |
| 3 | +$461K | |
| 4 |
VF
Virtu Financial
New York
|
+$299K |
| 5 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
+$233K |
Top Sellers
| 1 | -$4.95M | |
| 2 | -$4.88M | |
| 3 | -$4.43M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.83M |